GNG5 has been shown to play an important role in various cancers such as endometrial carcinoma [15] where it is highly expressed, and in invasive ductal carcinoma of the breast [16] where it regulates the secretion of E-cadherin through the Wnt signaling pathway. Here, GNG5 is linked to invasive ductal breast carcinoma.